NAVIGATOR365
LIVE

Serial Number

90758536

Owner

PRECISION FOR MEDICINE NL B.V.

Attorney

Donna H. Hartman

Filing Date

Jun 7, 2021

Add to watchlist:

No watchlists yet
View on USPTO

NAVIGATOR365 Trademark

Serial Number: 90758536 • Registration: 7424272

NAVIGATOR365 is a trademark filed by PRECISION FOR MEDICINE NL B.V. on June 7, 2021. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

PRECISION FOR MEDICINE NL B.V.

OTTERGEMSESTEENWEG-ZUID 808
GENT 9000 , BE

Entity Type: 24

Precision Medicine Group, LLC

2 Bethesda Metro Center, Suite 850
Bethesda, MD 20814

Entity Type: 16

Trademark Details

Filing Date

June 7, 2021

Registration Date

June 25, 2024

Published for Opposition

April 9, 2024

Goods & Services

Business services, namely, advertising, marketing, promotional consultancy, and advisory services; Electronic data collection, analysis, and data submission services of quality metric data for business purposes in the life sciences industry in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care; Business research services, namely, the creation, collection, analysis, provision of statistical and commercial data, and reporting in the life sciences industry in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care; Market research services in the nature of measuring, tracking, and demographic modeling of audiences for omnichannel activities in the life sciences industry in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care; Market research services in the nature of tracking and measuring audience viewing of, exposure to, and reactions to omnichannel campaign measurement and analysis, and demographic and geographic studies; Market research services in the nature of conducting audience validation services to verify the market impressions and demographics in the life sciences industry in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care; Delivery of solutions and other services, namely, marketing research services, development of marketing strategies and concepts, relating to and for use in marketing, sales measurement and analysis, product advertising and marketing strategies and tools, customer preferences and demands, product innovation and development, customers' purchasing decisions, histories and behaviors, competitor and market analysis, in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care; Business research services in the nature of analyzing, manipulating, and measuring data obtained from market data and the customization and personalization of data for clients to engage in solutions, generate reports and utilize dashboard analytics

Providing nondownloadable electronic publications in the nature of interactive, integrated, cloud-based and analytical reports in the fields of audience measurement, media exposure measurement, market research and business research; Delivery of solutions and other services, namely, providing online nondownloadable publications in the nature of data, charts, and tables in customizable reports, in the fields of marketing, sales measurement and analysis, product advertising and marketing strategies and tools, customer preferences and demands, product innovation and development, customers' purchasing decisions, histories and behaviors, competitor and market analysis, in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care

Providing software as a service (SAAS) services featuring cloud-based software for the life sciences industry for analyzing omnichannel customer data, customer relationship management, drafting industry reports, etc.in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care; Software as a service (SAAS) services, featuring software for industry analytics and business intelligence in the life sciences industry in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care; Providing software as a service (SAAS) services featuring software that enables users to search, analyze, and manipulate market data to generate reports and utilize dashboard analytics for the life sciences industry in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care; Delivery of solutions and other services, namely, providing online nondownloadable software for measuring and analyzing omnichannel customer data relating to and for use in marketing, sales measurement and analysis, product advertising and marketing strategies and tools, customer preferences and demands, product innovation and development, customers' purchasing decisions, histories and behaviors, competitor and market analysis, in the fields of medicine, pharmaceutical, biopharmaceutical, medical devices, nutrition, and health care

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 10, 2026 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 25, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 25, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 5, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 4, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 4, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 4, 2023 GNFN
FINAL REFUSAL E-MAILED
Dec 4, 2023 GNFR
FINAL REFUSAL WRITTEN
Dec 4, 2023 CNFR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 18, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
May 18, 2023 GNSL
SUSPENSION LETTER WRITTEN
May 18, 2023 CNSL
ASSIGNED TO EXAMINER
May 18, 2023 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 20, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 20, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 20, 2021 GNRN
NON-FINAL ACTION E-MAILED
Nov 20, 2021 GNRT
NON-FINAL ACTION WRITTEN
Nov 20, 2021 CNRT
ASSIGNED TO EXAMINER
Nov 17, 2021 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Sep 2, 2021 AMPX
ASSIGNED TO LIE
Sep 2, 2021 ALIE
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 27, 2021 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 15, 2021 PARI
NEW APPLICATION ENTERED
Jun 10, 2021 NWAP